Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis

[1]  Y. Takeuchi,et al.  Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. , 2004, The Journal of clinical investigation.

[2]  Di Chen,et al.  MEPE has the properties of an osteoblastic phosphatonin and minhibin. , 2004, Bone.

[3]  T. Craig,et al.  Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. , 2003, The Journal of clinical investigation.

[4]  L. Quarles,et al.  FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. , 2003, American journal of physiology. Endocrinology and metabolism.

[5]  M. Levine,et al.  Molecular pathogenesis of hypophosphatemic rickets. , 2002, The Journal of clinical endocrinology and metabolism.

[6]  R. Kumar,et al.  FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate. , 2001, Biochemical and biophysical research communications.

[7]  S. Takeda,et al.  Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  E. Bennett,et al.  cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-D-galactosamine. Polypeptide N-acetylgalactosaminyltransferase, GalNAc-t3. , 1996, The Journal of biological chemistry.

[9]  L Kruglyak,et al.  Parametric and nonparametric linkage analysis: a unified multipoint approach. , 1996, American journal of human genetics.

[10]  M. Daly,et al.  Rapid multipoint linkage analysis of recessive traits in nuclear families, including homozygosity mapping. , 1995, American journal of human genetics.

[11]  R. Slavin,et al.  Familial Tumoral Calcinosis: A Clinical, Histopathologic, and Ultrastructural Study with an Analysis of its Calcifying Process and Pathogenesis , 1993, The American journal of surgical pathology.

[12]  H. DeLuca,et al.  Elevated serum calcitriol concentrations do not fall in response to hyperphosphatemia in familial tumoral calcinosis. , 1985, American journal of diseases of children.

[13]  Y. Levy,et al.  X-Linked Lymphoproliferative Syndrome: A New Kindred With Variable Phenotypic Expression , 1985 .

[14]  M. Prince,et al.  Hyperphosphatemic tumoral calcinosis: association with elevation of serum 1,25-dihydroxycholecalciferol concentrations. , 1982, Annals of internal medicine.

[15]  R. Kumar,et al.  The phosphatonin pathway: new insights in phosphate homeostasis. , 2004, Kidney international.

[16]  Lawrence A Tabak,et al.  All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. , 2003, Glycobiology.